Skip to content

BeOne Medicines’ Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDA

By API User

Breakthrough designation based on early, positive results of a Phase 1/2 study of sonrotoclax in patients with relapsed or refractory mantle cell lymphoma (MCL) BeOne to participate in Project Orbis program, supporting efforts to rapidly advance global access SAN CARLOS, Calif.–BUSINESS WIRE– BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, … Continued

AdvanCell to Present Promising Clinical Trial Results of ADVC001, a Novel Lead-212-based PSMA-targeted Alpha Therapy for Prostate Cancer, at ESMO 2025

By API User

Results from the Phase 1b dose escalation of the TheraPb Phase 1/2 trial are the first clinical data for a Lead-212 (212Pb)-based-PSMA radioligand therapy The abstract presents a favorable safety profile for 212Pb-ADVC001 and promising anti-tumor activity, underscoring its potential to enhance therapeutic options for patients with metastatic prostate cancer The upcoming presentation at ESMO … Continued

Australians Support Replacement of Animals in Science

By API User

Key Facts: National poll reveals latest insights on public opinion on animal use in science Strongest opposition to lethal research and research involving dogs, cats or monkeys Support for funding of alternatives, greater transparency and rehoming  New National Poll Confirms Rising Support for Humane Alternatives A national poll commissioned by Animal-Free Science Advocacy (AFSA) reveals … Continued

EarlyHealth Group Acquires CYB3R, Gulf’s Fastest-Growing Cybersecurity Firm

By API User

DUBAI, United Arab Emirates, Oct. 12, 2025 (GLOBE NEWSWIRE) — EarlyHealth Group, a global pharmaceutical services and life sciences solutions company, has acquired a 50 % equity stake in CYB3R Limited, one of the Gulf’s fastest-growing cybersecurity firms headquartered in Dubai. This strategic diversification and cross-industry investment positions CYB3R with a global footprint whilst expanding … Continued

Fast, effective online therapy helps people overcome social anxiety

By API User

MEDIA RELEASE Fast, effective online therapy helps people overcome social anxiety [EMBARGOED 00:01 13/10/2025] A new UNSW Sydney and Black Dog Institute study has found that an intensive, one-week online therapy program can significantly reduce symptoms of social anxiety disorder (SAD)—the most common anxiety disorder in Australia, affecting around one in seven people each year. … Continued

https://doi.org/10.1016/j.janxdis.2025.103073

By API User

Fast, effective online therapy helps people overcome social anxiety [EMBARGOED 00:01 13/10/2025] A new UNSW Sydney and Black Dog Institute study has found that an intensive, one-week online therapy program can significantly reduce symptoms of social anxiety disorder (SAD)—the most common anxiety disorder in Australia, affecting around one in seven people each year. Published in … Continued